The effects of lycopene on cisplatin-induced ototoxicity

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 12, 2013, Pages 3027-3033

  Özkiriş, Mahmut ^a   Kapusuz, Zeliha ^a   Karaçavuş, Seyhan ^a   Saydam, Levent ^a  

^a BOZOK UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Lycopene; Ototoxicity

Indexed keywords

CISPLATIN; LYCOPENE; REDIVIVO; UNCLASSIFIED DRUG;

ANALYZER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DAMAGE; CHEMOPROPHYLAXIS; CILIATED EPITHELIUM; COMPUTER PROGRAM; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SPINAL GANGLION; STRIA VASCULARIS;

ANIMALS; CAROTENOIDS; CISPLATIN; COCHLEA; FEMALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

EID: 84889665102     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-013-2352-0     Document Type: Article

References (28)

1. Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33:9-23
2. Borges GC, Borges RHM, Baraúna GN, Lopes Filho O (2001) Ototoxicidade causada pela cisplatina em crianças. Estudo retrospectivo. Rev Bras Otorrinolaringol 67:292-295
3. Merrin C (1978) Treatment of advanced bladder cancer with cisplatinum. J Urol 119:493-495
4. Helson L, Okonkwo E, Anton L, Critkovic E (1978) Cisplatinum ototoxicity. Clin Toxicol 13:493-495
5. Kopelman J, Budnick AS, Kramer MB, Sessions RB, Wong GYB (1998) Ototoxicity in high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 98:858-864
6. Sockalingam R, Freeman S, Cherny TL, Sohmer H (2000) Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol 21:521-527
7. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F (2000) Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 28:73-80
8. Daldal A, Odabasi O, Serbetcioglu B (2007) The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137:747-752
9. Kalkanis JG, Whitworth C, Rybak LP (2004) Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114:538-542
10. Kasse CA, Cruz OL, Iha LC, Costa HO, Lopes EC, Coelho F (2008) The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity. Braz J Otorhinolaryngol 74:712-717
11. Feghali JG, Liu W, Van De Water TR (2001) l-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147-1155
12. Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81-89
13. Campbell KC, Meech RP, Rybak LP, Hughes LF (1999) d-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 138:13-28
14. Kelly TC, Whitworth CA, Husain K, Rybak LP (2003) Aminoguanidine reduces cisplatin ototoxicity. Hear Res 186:10-16
15. Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B (2004) The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int J Audiol 43:465-470
16. Huang X, Whitworth CA, Rybak LP (2007) Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28:828-833
17. Teranishi MA, Nakashima T (2003) Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 67:133-139
18. Jonker D, Kuper CF, Estrella A, Rodrigues Otero C (2003) Ninety day oral toxicity study of lycopene from Blakeslea trispora in rats. Regul Toxicol Phamacol 37:396-406
19. Srinivasan M, Sudheer AR, Pillai KR, Kumar PR, Sudhakaran PR, Menon VP (2007) Lycopene as a natural protector against γ- radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes in vitro. Biochim Biophys Acta 1770:659-665
20. Kumar P, Kumar A (2009) Effect of lycopene and epigallocatechin- 3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol 47:2522-2530
21. Mordente A, Guantario B, Meucci E, Silvestrini A, Lombardi E, Martorana GE, Giardina B, Böhm V (2011) Lycopene and cardiovascular diseases: an update. Curr Med Chem 18:1146-1163
22. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A (2005) Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212:116-123
23. de Freitas MR, de Castro Brito GA, de Carvalho JV Jr, Gomes RM Jr, Barreto Martins MJ, de Albuquerque Ribeiro R (2009) Light microscopy study of cisplatin-induced ototoxicity in rats. J Laryngol Otol 123:590-597
24. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F (2000) Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 28:73-80
25. Ozturan O, Jerger J, Lew H, Lynch GR (1996) Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions. Auris Nasus Larynx 23:147-151
26. Bignotto L, Rocha J, Sepodes B, Eduardo-Figueira M, Pinto R, Chaud M, de Carvalho J, Moreno H Jr, Mota-Filipe H (2009) Anti-inflammatory effect of lycopene on carrageenan-induced paw edema and hepatic ischemia-reperfusion in the rat. Br J Nutr 102:126-133
27. Reifen R, Nissenkorn A, Matas Z, Bujanover Y (2004) 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol 39:514-519
28. Boileau TW, Boileau AC, Erdman JW Jr (2002) Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med (Maywood) 227:914-919